Willow Biosciences Inc
TSX:WLLW

Watchlist Manager
Willow Biosciences Inc Logo
Willow Biosciences Inc
TSX:WLLW
Watchlist
Price: 0.17 CAD Market Closed
Market Cap: 107m CAD

Willow Biosciences Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Willow Biosciences Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Willow Biosciences Inc
TSX:WLLW
Cash from Operating Activities
-CA$2.2m
CAGR 3-Years
51%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash from Operating Activities
$7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$70.1m
CAGR 3-Years
N/A
CAGR 5-Years
-95%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
$120.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Cash from Operating Activities
-$252m
CAGR 3-Years
-43%
CAGR 5-Years
-75%
CAGR 10-Years
-32%
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$9.1m
CAGR 3-Years
2%
CAGR 5-Years
-115%
CAGR 10-Years
0%
No Stocks Found

Willow Biosciences Inc
Glance View

Market Cap
107m CAD
Industry
Biotechnology

Willow Biosciences, Inc. is a biotechnology company. The company is headquartered in Calgary, Alberta and currently employs 49 full-time employees. The company went IPO on 2017-09-14. The firm's products include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV), cannabigerovarin (CBGV), tetrahydrocannabivarin (THCV) and cannabinol (CBN). The firm has two laboratories for research and development in Mountain View, California and Burnaby, British Columbia. In addition, the Company has an analytical testing lab in Burnaby where it provides third-party analytical testing and product development services to the cannabis industry through its subsidiary Willow Analytics Inc. The company also offers testing for all forms of cannabis products, including flower, concentrates and extracted ingredients.

WLLW Intrinsic Value
HIDDEN
Show

See Also

What is Willow Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
-2.2m CAD

Based on the financial report for Mar 31, 2025, Willow Biosciences Inc's Cash from Operating Activities amounts to -2.2m CAD.

What is Willow Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
29%

Over the last year, the Cash from Operating Activities growth was 76%. The average annual Cash from Operating Activities growth rates for Willow Biosciences Inc have been 51% over the past three years , 29% over the past five years .

Back to Top